Treventis CEO invited speaker, panelist at XV International Pharma Licensing Symposium

Treventis CEO Christopher Barden was honored to be an invited speaker at the XV International Pharma Licensing Symposium, running from Sep 18-20, 2019, in Paris, France.

This year’s topic was “Disruption or Evolution? Contemporary Trends in Pharma Business Development.” Topics at this year’s IPLS included artificial intelligence, medical cannabis, diseases of aging, and evolution of business development teams. Dr. Barden presented a talk on Treventis’s technology and programs in protein misfolding disease therapeutics. He also participated on a panel discussion about diseases of aging, in which the concept of “aging as a disease” was explored and the likely medium- and long-term trends in pharmaceutical treatment of aging were considered.